A Novel Antidiabetic Monomers Combination Alleviates Insulin Resistance Through Bacteria-Cometabolism-Inflammation Responses

Frontiers in Microbiology
Lin HanXiao-Lin Tong

Abstract

The present study sought to examine the therapeutic effect of a novel antidiabetic monomer combination (AMC) in treating type 2 diabetes mellitus (T2DM); while also elucidating the potential functional mechanism. Male C57BL/6J mice were fed a high-fat diet (HFD) for 12 weeks to establish T2DM. The AMC group showed significant reduction in weight, fasting blood glucose (FBG), serum total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C), and experienced reduced insulin resistance based on oral glucose tolerance testing (OGTT) and hyperinsulinemic-euglycemic clamp testing ("gold standard" for determining in vivo insulin sensitivity). Further, AMC restored the altered intestinal flora by increasing the abundance of the beneficial bacteria Akkermansia, and decreasing the number of harmful bacteria, including Bacteroides, Odoribacter, Prevotella 9, Alistipes, and Parabacteroides. Components of the host-microbial metabolome were also significantly changed in the AMC group compared to the HFD group, including hydroxyphenyllactic acid, palmitoleic acid, dodecanoic acid, linoleic acid, and erucic acid. Furthermore, AMC was found to inhibit inflammation and suppress signaling pathways related to insulin resistance. Lastly,...Continue Reading

References

Dec 15, 2006·Nature·Steven E KahnKristina M Utzschneider
Aug 24, 2012·The Proceedings of the Nutrition Society·Orla M FinucaneHelen M Roche
Oct 16, 2012·Journal of Biomedical Science·Natalia BeloborodovaNadezhda Fedotcheva
Aug 28, 2014·Molecular Metabolism·Kanakadurga SingerCarey Nien-Kai Lumeng
Jan 27, 2015·Trends in Immunology·Jan MauerJens C Brüning
Apr 3, 2015·The Journal of Nutrition·Linda C DuffyPamela Starke-Reed
Jul 15, 2016·Nature·Helle Krogh PedersenOluf Pedersen
Nov 23, 2017·Frontiers in Aging Neuroscience·Bryan J Neth, Suzanne Craft
Nov 29, 2017·Nature Microbiology·Anjelique F SchulferMartin J Blaser
Feb 3, 2018·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Kuo GaoJianxin Chen
May 11, 2018·Journal of Gastroenterology and Hepatology·Yan-Jie ChenXi-Zhong Shen
Aug 15, 2018·Nature Reviews. Molecular Cell Biology·Qin YangBarbara B Kahn
Aug 31, 2018·Journal of Agricultural and Food Chemistry·Li YuanYuyu Shao
Sep 10, 2018·The Journal of Nutritional Biochemistry·Suprabhat MukherjeeSanti P Sinha Babu
Sep 23, 2018·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Yongbo KangXiangyang Kong
Nov 6, 2018·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Xiang XiangJin-Ao Duan
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yihan WuJinming Zhang
Dec 21, 2018·Critical Reviews in Food Science and Nutrition·Qixing NieShaoping Nie
Feb 13, 2019·European Heart Journal·Mahesh BavineniJawahar L Mehta
May 11, 2019·Trends in Endocrinology and Metabolism : TEM·Max Friesen, Chad A Cowan

❮ Previous
Next ❯

Datasets Mentioned

BETA
PRJNA593365

Methods Mentioned

BETA
protein assay
electrophoresis
16S sequencing
PCR
metabolomics profiling
PCA

Software Mentioned

Gel Image System
SPSS
XploreMET

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.